Vice President Biologics

Location: Chengdu, China (Relocation Supported), the first year of employment can be remote.

Are you the right applicant for this opportunity Find out by reading through the role overview below.

BioTalent is conducting a search for a senior biologics R&D executive to lead a large-scale innovation organization focused on next-generation immunology and oncology drug development.

We are looking for a leader currently based in North America who is interested in relocating to China to lead a major biologics R&D organization.

This is a rare opportunity to take ownership of a biologics portfolio spanning tumor immunology, T-cell engagers (TCEs), ADCs, and next-generation immunotherapies. Reporting directly to the Chairman and President, this leader will shape R&D strategy, drive scientific innovation, and build a globally competitive pipeline with strong partnering and out-licensing potential.

Key Responsibilities

• Define and execute biologics portfolio strategy aligned with unmet clinical needs.
• Lead scientific direction across tumor immunology, PD-1 based therapies, TCEs, multispecific antibodies, and ADC programs.
• Drive innovation through assessment and implementation of novel platform technologies.
• Guide programs from discovery through IND-enabling studies and clinical translation.
• Partner with clinical development teams on early-stage clinical strategy and protocol design.
• Lead, develop, and scale multidisciplinary R&D teams across discovery, preclinical, and process development.
• Support business development activities through scientific due diligence and asset evaluation.
• Bilingual in English and Mandarin

Ideal Background

• PhD in Immunology, Tumor Biology, or a related life sciences discipline.
• 10+ years of biologics drug discovery and development experience within biotech or large pharmaceutical environments.
• 5+ years of leadership experience at Director level or above.
• Demonstrated success advancing biologics programs from target discovery through IND.
• Deep expertise in tumor immunology, PD-1 mechanisms, T-cell engagers, bispecific antibodies, or ADCs.
• Experience supporting successful licensing transactions or advancing assets into clinical development strongly preferred.
• Strong strategic leadership capabilities combined with scientific excellence.

Relocation Package

• Family accommodation provided.
• Company vehicle provided.
• Flexible remote working arrangements. xhyhwjd
• Significant opportunity to influence global biologics innovation strategy.